Colorado Experts, Including CU Pharmacy Professor, Prepare ‘Blueprint’ for Opioid Litigation Settlements

By | In the News | No Comments
Professor Rob Valuck

Colorado experts in combatting substance abuse are recommending ways cities, counties, and the state could use dollars anticipated from the settlement of lawsuits against companies and individuals involved in fostering the opioid crisis. In a report released December 5, experts recommend ways community and state leaders can put the money to use quickly and effectively. Read More

Faculty research evaluates innovative but costly cancer therapy in Journal of Clinical Oncology review article

By | In the News | No Comments

A 2017 video explains CAR-T cancer therapies and the research conducted by the Pharmaceutical Outcomes Research faculty at CU Pharmacy.

After conducting pioneering research into the cost-effectiveness of an innovative new cancer treatment, researchers at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS) were invited by the Journal of Clinical Oncology to contribute a review article in an upcoming special issue, “Economic Issues in Cancer Care.” Read More

CU Pharmacy ambulatory care residency program, faculty member recognized as best in country

By | In the News | No Comments
Ambulatory Care Residency Program Director Joe Saseen, center, smiles for a photo with current residents (left to right) Navya Varshney, Vivian Cheng, Jennifer Tunoa and Joe Nardolillo.

A map hanging in Dr. Joe Saseen’s office at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences is marked with pins in cities across the country, each representing former residents trained by the CU Pharmacy Ambulatory Care Residency Program. Read More

Student gives speech

Student recognizes generosity of donors in speech at scholarship luncheon

By | In the News | No Comments

Note: The following is a speech delivered by University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences student Clare Livingston at the school’s scholarship luncheon on Nov. 1. The luncheon brought together CU Pharmacy’s generous scholarship donors and their recipients.

I would like to start by welcoming everyone to this delicious luncheon to celebrate scholarship donors and recipients at the Skaggs School of Pharmacy. My name is Clare Livingston and I am a P4 student. I am currently the recipient of the James L McDowell Scholarship and a former recipient of the Kent M. Nelson and Erwin-Nelson Scholarships. Read More

Headshots of Next-Generation Award finalists

CU Pharmacy faculty members and student honored at Next-Generation Pharmacist Awards

By | In the News | No Comments

Two University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences faculty members and a student were honored with awards that recognize pharmacy innovators from across the U.S.

Associate Professor Sarah Anderson, PharmD, Assistant Professor Rhianna Fink, PharmD, and student Nashel Patel were all honored in the Next-Generation Pharmacy Awards, sponsored by Pharmacy Times and Parata Systems. The awards honor 30 finalists from across the country in 10 categories. Read More

Clinical trial: How a CU Pharmacy professor’s research is helping people with severe epilepsy

By | Faculty Perspectives, In the News | No Comments

Video courtesy of Stephanie Carlson, Digital Media Manager, 9Health

For patients with a severe form of epilepsy, it can be dangerous to drive, go to work or even walk to the mailbox alone. A fear of falling and blacking out prevents many patients with medically refractory epilepsy from living lives most people take for granted.

“They can’t have a job, they can’t really live a normal life,” said Tom Anchordoquy, PhD, professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. “These patients, before, had to always have someone with them because there was a fear of seizures.”

On top of that, the drugs patients with the severe form of epilepsy take to manage their disorder — which are needed in high concentrations in the brain — are typically taken orally and then distributed throughout the entire body, resulting in problematic side effects. Read More